Published in Endocrinology on November 16, 2012
Female-specific induction of rat pituitary dentin matrix protein-1 by GnRH. Mol Endocrinol (2013) 0.81
Calcium signaling properties of a thyrotroph cell line, mouse TαT1 cells. Cell Calcium (2015) 0.75
Ion Channels of Pituitary Gonadotrophs and Their Roles in Signaling and Secretion. Front Endocrinol (Lausanne) (2017) 0.75
KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel. Science (1998) 7.32
International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacol Rev (1998) 5.34
A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment. Mol Pharmacol (1992) 3.20
Alpha 9: an acetylcholine receptor with novel pharmacological properties expressed in rat cochlear hair cells. Cell (1994) 3.03
International Union of Pharmacology. LII. Nomenclature and molecular relationships of calcium-activated potassium channels. Pharmacol Rev (2005) 2.39
Role of alpha9 nicotinic ACh receptor subunits in the development and function of cochlear efferent innervation. Neuron (1999) 2.01
Nicotinic acetylcholine receptors: from structure to brain function. Rev Physiol Biochem Pharmacol (2003) 1.99
GnRH-induced Ca2+ oscillations and rhythmic hyperpolarizations of pituitary gonadotropes. Science (1992) 1.58
Simultaneous visualization of multiple antigens with tyramide signal amplification using antibodies from the same species. J Histochem Cytochem (2007) 1.54
Muscarinic regulation of intracellular signaling and neurosecretion in gonadotropin-releasing hormone neurons. Endocrinology (1998) 1.53
Partial agonist properties of cytisine on neuronal nicotinic receptors containing the beta 2 subunit. Mol Pharmacol (1994) 1.44
Molecular mechanisms of ligand interaction with the gonadotropin-releasing hormone receptor. Endocr Rev (1997) 1.37
Competitive neuronal nicotinic receptor antagonists: a new direction for drug discovery. J Pharmacol Exp Ther (2001) 1.25
Paracrinicity: the story of 30 years of cellular pituitary crosstalk. J Neuroendocrinol (2008) 1.24
Ca2+ excitability of the ER membrane: an explanation for IP3-induced Ca2+ oscillations. Am J Physiol (1995) 1.20
InsP3-induced Ca2+ excitability of the endoplasmic reticulum. Mol Biol Cell (1995) 1.19
Muscarinic acetylcholine receptors. Curr Pharm Des (2006) 1.18
Muscarinic receptor subtypes in human bladder detrusor and mucosa, studied by radioligand binding and quantitative competitive RT-PCR: changes in ageing. Br J Pharmacol (2005) 1.17
Ion channels and signaling in the pituitary gland. Endocr Rev (2010) 1.14
Allosteric modulators of the alpha7 nicotinic acetylcholine receptor. J Med Chem (2008) 1.14
Two neuronal nicotinic acetylcholine receptors, alpha4beta4 and alpha7, show differential agonist binding modes. J Biol Chem (2011) 1.08
cAMP directly facilitates Ca-induced exocytosis in bovine lactotrophs. FEBS Lett (1990) 1.07
Nicotinic acetylcholine receptor transmembrane mutations convert ivermectin from a positive to a negative allosteric modulator. Mol Pharmacol (2010) 1.06
Nicotinic acetylcholine receptors in porcine hypophyseal intermediate lobe cells. J Physiol (1990) 1.03
Neural regulation of luteinizing hormone secretion in the rat. Endocr Rev (1983) 1.02
Apamin-sensitive potassium channels mediate agonist-induced oscillations of membrane potential in pituitary gonadotrophs. FEBS Lett (1992) 1.01
Nicotinic acetylcholine receptor-based blockade: applications of molecular targets for cancer therapy. Clin Cancer Res (2011) 0.97
Recent progress in the development of subtype selective nicotinic acetylcholine receptor ligands. Curr Drug Targets CNS Neurol Disord (2002) 0.93
Activity of nAChRs containing alpha9 subunits modulates synapse stabilization via bidirectional signaling programs. Dev Neurobiol (2009) 0.92
An intermediate-conductance Ca(2+)-activated K (+) channel mediates B lymphoma cell cycle progression induced by serum. Pflugers Arch (2007) 0.91
A neurogenic timing factor in control of the ovulatory discharge of luteinizing hormone in the cyclic rat. Endocrinology (1949) 0.91
Muscarinic acetylcholine receptor activation causes inhibition of cyclic AMP accumulation, prolactin and growth hormone secretion in GH3 rat anterior pituitary tumour cells. Biochim Biophys Acta (1984) 0.90
Recent advances in understanding the structure of nicotinic acetylcholine receptors. IUBMB Life (2009) 0.84
Effect of acetylcholine on the electrical and secretory activities of frog pituitary melanotrophs. Brain Res (1990) 0.84
Evidence for functional atypical nicotinic receptors that activate K+-dependent Cl- secretion in mouse tracheal epithelium. Am J Respir Cell Mol Biol (2012) 0.83
Muscarinic M(3) receptor-dependent regulation of airway smooth muscle contractile phenotype. Br J Pharmacol (2004) 0.83
Synthesis and release of acetylcholine by normal and tumoral pituitary corticotrophs. Endocrinology (1989) 0.83
Cholinergic afferents to gonadotropin-releasing hormone neurons of the rat. Neurochem Int (2007) 0.82
Effects of the phospholipase-C inhibitor, U73122, on signaling and secretion in pituitary gonadotrophs. Endocrinology (1995) 0.82
Acetylcholine stimulates alpha-melanocyte-stimulating hormone release from frog pituitary melanotrophs through activation of muscarinic and nicotinic receptors. Endocrinology (1989) 0.81
In GH3 pituitary cells, acetylcholine and vasoactive intestinal peptide antagonistically modulate adenylate cyclase, cyclic AMP content, and prolactin secretion. Mol Pharmacol (1983) 0.81
Muscarinic cholinergic inhibition of cyclic AMP formation and adrenocorticotropin secretion in mouse pituitary tumor cells. Biochem Biophys Res Commun (1983) 0.81
Acetylcholine and the release of the follicle-stimulating hormone-releasing factor. Endocrinology (1974) 0.81
Acetylcholine stimulates growth hormone secretion, phosphatidyl inositol labelling, 45Ca2+ efflux and cyclic GMP accumulation in bovine anterior pituitary glands. J Endocrinol (1979) 0.81
Evidence for a cholinergic component in the neuroendocrine control of luteinizing hormone (LH) secretion. Neuroendocrinology (1975) 0.80
Acetylcholine receptors in the rat anterior pituitary gland. Endocrinology (1980) 0.80
Immunocytochemical and pharmacological evidence for an intrinsic cholinomimetic system modulating prolactin and growth hormone release in rat pituitary. Endocrinology (1988) 0.80
Blockade of the release of gonadotropins and prolactin by subcutaneous or intraventricular injection of atropine in male and female rats. Endocrinology (1973) 0.80
Cloning and characterization of alpha9 subunits of the nicotinic acetylcholine receptor expressed by saccular hair cells of the rainbow trout (Oncorhynchus mykiss). Neuroscience (2004) 0.80
Muscarinic involvement in the regulation of gonadotropin-releasing hormone in the cyclic rat. Mol Cell Endocrinol (1992) 0.79
Muscarinic receptor binding in sheep anterior pituitary. Neuroendocrinology (1980) 0.79
Neosurugatoxin: CNS acetylcholine receptors and luteinizing hormone secretion in ovariectomized rats. Brain Res Bull (1988) 0.78
The glucocorticoid hormone dexamethasone reverses the growth hormone-releasing properties of the cholinomimetic carbachol. Endocrinology (1989) 0.78
Pituitary cell cultures contain muscarinic receptors. Eur J Pharmacol (1980) 0.78
Intracellular distribution of functional M(1) -muscarinic acetylcholine receptors in N1E-115 neuroblastoma cells. J Neurochem (2011) 0.77
Acetylcholine autoexcites the release of proopiomelanocortin-derived peptides from melanotrope cells of Xenopus laevis via an M1 muscarinic receptor. Endocrinology (1996) 0.77
Third ventricular injection of alpha-bungarotoxin decreases pulsatile luteinizing hormone secretion in the ovariectomized rat. Neuroendocrinology (1989) 0.76
Acetylcholine increases intracellular Ca2+ in the rat pituitary folliculostellate cells in primary culture. Am J Physiol Endocrinol Metab (2001) 0.76
Stimulation and inhibition of prolactin release from rat pituitary lactotrophs by the cholinomimetic carbachol in vitro. Influence of hormonal environment and intercellular contacts. Mol Cell Endocrinol (1989) 0.76
Blockade of the postorchidectomy increase in gonadotropins by implants of atropine into the hypothalamus. Proc Soc Exp Biol Med (1976) 0.76
More pieces of the puzzle in place, even more discovered missing. Endocrinology (1998) 0.76
Calcium influx through neuronal-type nicotinic acetylcholine receptors present on the neuroendocrine cells of the porcine pars intermedia. Neuroendocrinology (1994) 0.76
Acetylcholine, melatonin, and potassium depolarization stimulate release of luteinizing hormone-releasing hormone from rat hypothalamus in vitro. Proc Natl Acad Sci U S A (1982) 0.76
The median eminence as a model to study presynaptic regulation of neural peptide release. Peptides (1982) 0.76
Inhibitory effect of melatonin on gonadotropin-releasing hormone-induced Ca2+ oscillations in pituitary cells of newborn rats. Neuroendocrinology (1997) 0.76
Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation. N Engl J Med (2014) 4.00
Activation and regulation of purinergic P2X receptor channels. Pharmacol Rev (2011) 2.14
The P2X7 receptor channel pore dilates under physiological ion conditions. J Gen Physiol (2008) 1.57
P2X7 receptor-deficient mice are susceptible to bone cancer pain. Pain (2011) 1.53
Dependence of STIM1/Orai1-mediated calcium entry on plasma membrane phosphoinositides. J Biol Chem (2009) 1.36
F(ab)'2-mediated neutralization of C3a and C5a anaphylatoxins: a novel effector function of immunoglobulins. Nat Med (2003) 1.28
Hydroxyurea nitrosylates and activates soluble guanylyl cyclase in human erythroid cells. Blood (2007) 1.27
Experimental characterization and mathematical modeling of P2X7 receptor channel gating. J Neurosci (2010) 1.25
Molecular determinants of the agonist binding domain of a P2X receptor channel. Mol Pharmacol (2005) 1.23
Participation of the Lys313-Ile333 sequence of the purinergic P2X4 receptor in agonist binding and transduction of signals to the channel gate. J Biol Chem (2006) 1.23
Connexin 26 regulates epidermal barrier and wound remodeling and promotes psoriasiform response. J Clin Invest (2006) 1.22
Mechanism of spontaneous and receptor-controlled electrical activity in pituitary somatotrophs: experiments and theory. J Neurophysiol (2007) 1.19
Allosteric modulation of ATP-gated P2X receptor channels. Rev Neurosci (2011) 1.16
Hydroxyurea induces the eNOS-cGMP pathway in endothelial cells. Blood (2006) 1.12
Identification of P2X4 receptor-specific residues contributing to the ivermectin effects on channel deactivation. Biochem Biophys Res Commun (2006) 1.12
Intracellular calcium measurements as a method in studies on activity of purinergic P2X receptor channels. Am J Physiol Cell Physiol (2003) 1.10
Role of aromatic and charged ectodomain residues in the P2X(4) receptor functions. J Neurochem (2007) 1.10
Identification of P2X(4) receptor transmembrane residues contributing to channel gating and interaction with ivermectin. Pflugers Arch (2008) 1.08
Expression and roles of pannexins in ATP release in the pituitary gland. Endocrinology (2011) 1.04
Carboxyl-terminal splicing enhances physical interactions between the cytoplasmic tails of purinergic P2X receptors. Mol Pharmacol (2006) 1.00
Calcium-dependent block of P2X7 receptor channel function is allosteric. J Gen Physiol (2011) 0.97
Contribution of multidrug resistance protein MRP5 in control of cyclic guanosine 5'-monophosphate intracellular signaling in anterior pituitary cells. Endocrinology (2006) 0.97
Dependence of electrical activity and calcium influx-controlled prolactin release on adenylyl cyclase signaling pathway in pituitary lactotrophs. Mol Endocrinol (2006) 0.94
Role of nucleotide P2 receptors in calcium signaling and prolactin release in pituitary lactotrophs. J Biol Chem (2003) 0.92
Release and extracellular metabolism of ATP by ecto-nucleotidase eNTPDase 1-3 in hypothalamic and pituitary cells. Purinergic Signal (2005) 0.92
Identification of ectodomain regions contributing to gating, deactivation, and resensitization of purinergic P2X receptors. J Neurosci (2004) 0.91
Heteromultimerization modulates P2X receptor functions through participating extracellular and C-terminal subdomains. J Biol Chem (2002) 0.91
Purinergic P2X(2) receptor desensitization depends on coupling between ectodomain and C-terminal domain. Mol Pharmacol (2002) 0.91
Dependence of multidrug resistance protein-mediated cyclic nucleotide efflux on the background sodium conductance. Mol Pharmacol (2009) 0.91
Two open states of P2X receptor channels. Front Cell Neurosci (2013) 0.91
Molecular, pharmacological and functional properties of GABA(A) receptors in anterior pituitary cells. J Physiol (2008) 0.90
Role of nonselective cation channels in spontaneous and protein kinase A-stimulated calcium signaling in pituitary cells. Am J Physiol Endocrinol Metab (2011) 0.90
Functional relevance of aromatic residues in the first transmembrane domain of P2X receptors. J Neurochem (2009) 0.89
Dopamine inhibits basal prolactin release in pituitary lactotrophs through pertussis toxin-sensitive and -insensitive signaling pathways. Endocrinology (2007) 0.89
Gating properties of the P2X2a and P2X2b receptor channels: experiments and mathematical modeling. J Gen Physiol (2012) 0.88
Characterization of purinergic P2X4 receptor channels expressed in anterior pituitary cells. Am J Physiol Endocrinol Metab (2009) 0.88
Reactive oxygen species potentiate the P2X2 receptor activity through intracellular Cys430. J Neurosci (2009) 0.87
Molecular dissection of purinergic P2X receptor channels. Ann N Y Acad Sci (2005) 0.87
Dual gating mechanism and function of P2X7 receptor channels. Biophys J (2013) 0.86
Characterization of novel Pannexin 1 isoforms from rat pituitary cells and their association with ATP-gated P2X channels. Gen Comp Endocrinol (2011) 0.86
Roles of purinergic P2X receptors as pacemaking channels and modulators of calcium-mobilizing pathway in pituitary gonadotrophs. Mol Endocrinol (2006) 0.85
ZD7288 inhibits exocytosis in an HCN-independent manner and downstream of voltage-gated calcium influx in pituitary lactotrophs. Biochem Biophys Res Commun (2006) 0.84
Calcium-independent and cAMP-dependent modulation of soluble guanylyl cyclase activity by G protein-coupled receptors in pituitary cells. J Biol Chem (2002) 0.84
cAMP-mediated stabilization of fusion pores in cultured rat pituitary lactotrophs. J Neurosci (2013) 0.83
Multiple roles of the extracellular vestibule amino acid residues in the function of the rat P2X4 receptor. PLoS One (2013) 0.83
Allosteric regulation of the P2X4 receptor channel pore dilation. Pflugers Arch (2014) 0.83
Ca(2+)-mobilizing endothelin-A receptors inhibit voltage-gated Ca(2+) influx through G(i/o) signaling pathway in pituitary lactotrophs. Mol Pharmacol (2002) 0.82
The expression and role of hyperpolarization-activated and cyclic nucleotide-gated channels in endocrine anterior pituitary cells. Mol Endocrinol (2011) 0.82
Receptor-controlled phosphorylation of alpha 1 soluble guanylyl cyclase enhances nitric oxide-dependent cyclic guanosine 5'-monophosphate production in pituitary cells. Mol Endocrinol (2003) 0.82
Up-regulation of ectonucleotidase activity after cortical stab injury in rats. Cell Biol Int (2006) 0.81
Conserved ectodomain cysteines are essential for rat P2X7 receptor trafficking. Purinergic Signal (2012) 0.81
Elucidation of mechanisms of the reciprocal cross talk between gonadotropin-releasing hormone and prostaglandin receptors. Endocrinology (2010) 0.81
Female-specific induction of rat pituitary dentin matrix protein-1 by GnRH. Mol Endocrinol (2013) 0.81
Gap junction remodelling is involved in the susceptibility of diabetic rats to hypokalemia-induced ventricular fibrillation. Acta Histochem (2002) 0.81
Atrazine acts as an endocrine disrupter by inhibiting cAMP-specific phosphodiesterase-4. Toxicol Appl Pharmacol (2012) 0.80
The role of cyclic nucleotides in pituitary lactotroph functions. Front Endocrinol (Lausanne) (2013) 0.80
Cloning and functional identification of novel endothelin receptor type A isoforms in pituitary. Mol Endocrinol (2007) 0.80
Endothelin-induced, long lasting, and Ca2+ influx-independent blockade of intrinsic secretion in pituitary cells by Gz subunits. J Biol Chem (2005) 0.80
Dependence of purinergic P2X receptor activity on ectodomain structure. J Biol Chem (2003) 0.79
Loss of basal and TRH-stimulated Tshb expression in dispersed pituitary cells. Endocrinology (2015) 0.79
Cell-type specific messenger functions of extracellular calcium in the anterior pituitary. Endocrinology (2002) 0.78
Biochemical characterization of soluble nucleotide pyrophosphatase/phosphodiesterase activity in rat serum. Mol Cell Biochem (2010) 0.78
Expression of ecto-nucleoside triphosphate diphosphohydrolase1-3 (NTPDase1-3) by cortical astrocytes after exposure to pro-inflammatory factors in vitro. J Mol Neurosci (2013) 0.78
Early temporal changes in ecto-nucleotidase activity after cortical stab injury in rat. Neurochem Res (2007) 0.78
Ribavirin ameliorates experimental autoimmune encephalomyelitis in rats and modulates cytokine production. Int Immunopharmacol (2008) 0.78
Hyperbaric oxygenation improves locomotor ability by enhancing neuroplastic responses after cortical ablation in rats. Brain Inj (2012) 0.78
Ribavirin shows immunomodulatory effects on activated microglia. Immunopharmacol Immunotoxicol (2014) 0.78
Norepinephrine causes a biphasic change in mammalian pinealocye membrane potential: role of alpha1B-adrenoreceptors, phospholipase C, and Ca2+. Endocrinology (2011) 0.78
Chicken 11beta-hydroxysteroid dehydrogenase type 2: partial cloning and tissue distribution. Steroids (2007) 0.77
Parallelism and dissociation in the actions of an Aroclor 1260-based transformer fluid on testicular androgenesis and antioxidant enzymes. Toxicology (2003) 0.77
Nitric oxide inhibits prolactin secretion in pituitary cells downstream of voltage-gated calcium influx. Endocrinology (2003) 0.77
The effect of ribavirin on reactive astrogliosis in experimental autoimmune encephalomyelitis. J Pharmacol Sci (2012) 0.77
Glucocorticoid metabolism and Na+ transport in chicken intestine. J Exp Zool A Comp Exp Biol (2005) 0.77
Novel aspects of growth hormone (GH) autoregulation: GH-induced GH gene expression in grass carp pituitary cells through autocrine/paracrine mechanisms. Endocrinology (2004) 0.77
Regulation of ecto-5'-nucleotidase (CD73) in cultured cortical astrocytes by different inflammatory factors. Neurochem Int (2012) 0.77
Effects of isoquinolonesulfonamides on action potential secretion coupling in pituitary cells. Horm Mol Biol Clin Investig (2010) 0.77
Time-course changes in ectonucleotidase activities during experimental autoimmune encephalomyelitis. Neurochem Int (2009) 0.76